C. M. Benjamin, S. Adam, S. Wiggins, J. L. Theilmann, T. T. Copley et al., Proceed with Care: Direct Predictive Testing for Huntington Disease, American Journal of Human Genetics, vol.55, issue.4, pp.606-617, 1994.

D. Borillo, Bioéthique à la française et paternalisme d'Etat. Raison publique, 2012.

L. Bortolotti and H. Widdows, The right not to know: The case of psychiatric disorders, Journal of Medical Ethics, vol.37, issue.11, pp.673-679, 2011.

M. Callon and V. Rabeharisoa, Gino's lesson on humanity: genetics, mutual entanglements and the sociologist's role, Economy and Society, vol.33, issue.1, pp.1-27, 2004.

L. Calzà, D. Beltrami, G. Gagliardi, E. Ghidoni, N. Marcello et al., Should we screen for cognitive decline and dementia?, Maturitas, vol.82, issue.1, pp.28-35, 2015.

G. Canguilhem, Le normal et le pathologique, 1966.

M. C. Carrillo, H. R. Brashear, V. Logovinsky, J. M. Ryan, H. H. Feldman et al., Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease, Alzheimer's & Dementia, vol.9, issue.2, pp.123-131, 2013.

S. M. Cox, Stories in Decisions: How At-Risk Individuals Decide to Request Predictive Testing for Huntington Disease, Qualitative Sociology, vol.26, issue.2, pp.257-280, 2003.

S. M. Cox and W. Mckellin, There's this thing in our family': Predictive testing and the construction of risk for Huntington Disease, Sociology of Health & Illness, vol.21, issue.5, pp.622-646, 1999.

A. Danion-grilliat, Conflits éthiques autour du diagnostic et du consentement : À propos de la psychiatrie et du diagnostic prénatal. L'information psychiatrique, vol.87, pp.557-566, 2012.

K. Dierickx, Dépistage génétique : y a-t-il un consentement éclairé ? Laennec, vol.51, pp.6-20, 2012.

B. Dubois, H. Hampel, H. H. Feldman, P. Scheltens, P. Aisen et al., Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria, Alzheimer's & Dementia, vol.12, issue.3, pp.292-323, 2016.

,

A. Durr, A. Herson, O. Rosenblum, and M. Gargiulo, Enjeux de la médecine prédictive en neurogénétique : Quelle place pour l'homme ? Champ psychosomatique, vol.55, pp.83-95, 2009.

, Essais thérapeutiques de prévention de la maladie d'Alzheimer ; De nouveaux enjeux pour l'éthique de la recherche ? Lyon, 2017.

, Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics, European Society of Human Genetics-ESHG, vol.17, issue.6, pp.720-721, 2009.

F. Eustache, Les stades précliniques de la maladie d'Alzheimer et leurs enjeux éthiques : Un autre défi pour la neuropsychologie, vol.4, pp.143-144, 2012.

G. Evers-kiebooms, M. Welkenhuysen, E. Claes, M. Decruyenaere, and L. Denayer, The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counselling and for genetic education, Social Science & Medicine, vol.51, issue.6, pp.64-66, 2000.

J. Fortea, A. Lladó, J. Clarimón, A. Lleó, R. Oliva et al., PICOGEN: Five years experience with a genetic counselling program for dementia, Neurologia, vol.26, issue.3, pp.143-149, 2011.

G. B. Frisoni and P. J. Visser, Biomarkers for Alzheimer's disease: A controversial topic, The Lancet Neurology, vol.14, issue.8, pp.150-157, 2015.

M. Gaboriau, L'information génétique familiale : Secret, autonomie et responsabilité. Cancer(s) et psy(s), pp.122-130, 2016.

S. Gauthier, A. Leuzy, E. Racine, and P. Rosa-neto, Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues, Progress in Neurobiology, vol.110, pp.102-113, 2013.

E. Geelen, I. V. Hoyweghen, and K. Horstman, Shaping the future and living in the present: Living a 'good' life with a familial heart disease, BioSocieties, vol.10, issue.1, pp.70-83, 2015.

A. E. Hall and H. Burton, Legal and ethical implications of inherited cardiac disease in clinical practice within the UK, Journal of Medical Ethics, vol.36, issue.12, pp.762-766, 2010.

A. Hedgecoe and G. Callon, La maladie d'Alzheimer, les spécialistes et les débats éthiques sur les tests génétiques, Sciences sociales et santé, vol.24, issue.1, pp.57-82, 2006.

D. Héron and M. Gargiulo, Tests génétiques et médecine prédictive : Quels enjeux ? Laennec, vol.57, pp.21-38, 2012.

P. G. Hess, H. M. Preloran, and C. H. Browner, Diagnostic genetic testing for a fatal illness: The experience of patients with movement disorders, New Genetics and Society, vol.28, issue.1, pp.3-18, 2009.

, Genetic Testing Protocol for Huntington's Disease. HDSA, 2016.

J. Husted, Autonomy and a right not to know, The Right to Know and the Right not to Know: Genetic Privacy and Responsibility. Aldershot: Ashgate, pp.24-37, 2014.

L. A. Jacobs and J. A. Deatrick, The individual, the family, and genetic testing, Journal of Professional Nursing, vol.15, issue.5, pp.313-324, 1999.

A. Jaunait, La relation de coopération médicale et l'asymétrie médecin-patient, Sciences sociales et santé, vol.25, issue.2, pp.67-72, 2007.

J. M. Kwon and R. D. Steiner, , 2011.

, I'm just waiting for my disease" The new and growing class of presymptomatic patients, Neurology, vol.77, issue.6, pp.522-523

J. Léger and J. Ouango, Dépistage précoce de la démence, Annonce du diagnostic et dimensions éthiques. Gérontologie et société, vol.97, pp.95-107, 2009.

Á. Leite, M. A. Dinis, J. Sequeiros, and C. Paúl, Motivation to perform presymptomatic testing in portuguese subjects at-risk for late-onset genetic diseases, Interdisciplinaria, vol.34, issue.1, pp.125-140, 2017.

A. Lippman, Prenatal Genetic Testing and Geneticization: Mother Matters for All, Fetal Diagnosis and Therapy, vol.8, pp.175-188, 1993.

A. Munnich, Les tests génétiques : Prédire ou médire ? Bulletin de l'Académie Nationale de Médecine, vol.184, pp.1009-1022, 2000.

A. Munnich, Programmé mais libre. Les malentendus de la génétique, 2016.

A. Munnich, V. Dragoni, M. Padis, and P. Weil-dubuc, La génétique est-elle inhumaine ?, Juillet, issue.7, pp.66-74, 2014.

C. Novas and N. Rose, Genetic Risk And The Birth of the Somatic Individual, Economy and Society, vol.29, issue.4, pp.485-513, 2000.

A. Pélissier, C. Peyron, and S. Béjean, Next-generation sequencing in clinical practice: From the patients' preferences to the informed consent process, Public Health, vol.138, pp.157-159, 2016.

V. Pihet, Dingdingdong -Institut de coproduction de savoir sur la maladie de Huntington ou l'art d'être concerné. Revue française d'éthique appliquée, pp.124-131, 2017.

D. Sicard, Les perspectives de la médecine préventive et prédictive. Revue française d'administration publique, vol.113, pp.121-125, 2005.

S. Timmermans and M. Buchbinder, Patients-in-Waiting: Living between Sickness and Health in the Genomics Era, Journal of Health and Social Behavior, vol.51, issue.4, pp.408-423, 2010.

P. Weil-dubuc, Autour du diagnostic présymptomatique. La Vie des idées, 2013.

J. K. Williams, D. L. Schutte, C. A. Evers, and C. Forcucci, Adults Seeking Presymptomatic Gene Testing for Huntington Disease, Image: The Journal of Nursing Scholarship, vol.31, issue.2, pp.109-114, 1999.